Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review
- PMID: 37269968
- DOI: 10.1016/j.mito.2023.05.007
Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review
Abstract
Misfolded proteins in the central nervous system can induce oxidative damage, which can contribute to neurodegenerative diseases in the mitochondria. Neurodegenerative patients face early mitochondrial dysfunction, impacting energy utilization. Amyloid-ß and tau problems both have an effect on mitochondria, which leads to mitochondrial malfunction and, ultimately, the onset of Alzheimer's disease. Cellular oxygen interaction yields reactive oxygen species within mitochondria, initiating oxidative damage to mitochondrial constituents. Parkinson's disease, linked to oxidative stress, α-synuclein aggregation, and inflammation, results from reduced brain mitochondria activity. Mitochondrial dynamics profoundly influence cellular apoptosis via distinct causative mechanisms. The condition known as Huntington's disease is characterized by an expansion of polyglutamine, primarily impactingthe cerebral cortex and striatum. Research has identified mitochondrial failure as an early pathogenic mechanism contributing to HD's selective neurodegeneration. The mitochondria are organelles that exhibit dynamism by undergoing fragmentation and fusion processes to attain optimal bioenergetic efficiency. They can also be transported along microtubules and regulateintracellular calcium homeostasis through their interaction with the endoplasmic reticulum. Additionally, the mitochondria produce free radicals. The functions of eukaryotic cells, particularly in neurons, have significantly deviated from the traditionally assigned role of cellular energy production. Most of them areimpaired in HD, which may lead to neuronal dysfunction before symptoms manifest. This article summarizes the most important changes in mitochondrial dynamics that come from neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's and Amyotrophic Lateral Sclerosis. Finally, we discussed about novel techniques that can potentially treat mitochondrial malfunction and oxidative stress in four most dominating neuro disorders.
Keywords: Alzheimer's diseases; Amyotrophic Lateral Sclerosis; Huntington's diseases; Mitochondrial dysfunction; Parkinson's diseases.
Copyright © 2023 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Mitochondrial diseases of the brain.Free Radic Biol Med. 2013 Oct;63:1-29. doi: 10.1016/j.freeradbiomed.2013.03.018. Epub 2013 Apr 6. Free Radic Biol Med. 2013. PMID: 23567191 Review.
-
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.Transl Neurodegener. 2022 Jul 4;11(1):36. doi: 10.1186/s40035-022-00308-y. Transl Neurodegener. 2022. PMID: 35787292 Free PMC article. Review.
-
Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.Int J Mol Sci. 2019 Nov 30;20(23):6055. doi: 10.3390/ijms20236055. Int J Mol Sci. 2019. PMID: 31801298 Free PMC article. Review.
-
Mitochondria and neurodegeneration.Biosci Rep. 2007 Jun;27(1-3):87-104. doi: 10.1007/s10540-007-9038-z. Biosci Rep. 2007. PMID: 17486441 Review.
-
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.J Neurol Sci. 2005 Jun 15;233(1-2):145-62. doi: 10.1016/j.jns.2005.03.012. J Neurol Sci. 2005. PMID: 15896810 Review.
Cited by
-
Novel Mitochondria-Targeted Amphiphilic Aminophosphonium Salts and Lipids Nanoparticles: Synthesis, Antitumor Activity and Toxicity.Nanomaterials (Basel). 2023 Oct 26;13(21):2840. doi: 10.3390/nano13212840. Nanomaterials (Basel). 2023. PMID: 37947686 Free PMC article.
-
Mitochondria targeted nanoparticles for the treatment of mitochondrial dysfunction-associated brain disorders.Front Bioeng Biotechnol. 2025 Mar 12;13:1563701. doi: 10.3389/fbioe.2025.1563701. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40144395 Free PMC article. Review.
-
Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer's Disease: A Critical Review of New and Old Little Regarded Findings.Int J Mol Sci. 2023 Nov 3;24(21):15951. doi: 10.3390/ijms242115951. Int J Mol Sci. 2023. PMID: 37958934 Free PMC article. Review.
-
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?Antioxidants (Basel). 2024 Feb 16;13(2):240. doi: 10.3390/antiox13020240. Antioxidants (Basel). 2024. PMID: 38397838 Free PMC article. Review.
-
Common microRNA regulated pathways in Alzheimer's and Parkinson's disease.Front Neurosci. 2023 Sep 1;17:1228927. doi: 10.3389/fnins.2023.1228927. eCollection 2023. Front Neurosci. 2023. PMID: 37719162 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical